Whilst the advantages of proteomics, as a functional phenotypic assessment of an individual are well known, the use of proteomics as an assessment of clinical phenotypes has been underutilised, especially when it comes to children. This presentation will outline examples where proteomics and specifically SWATH-MS is being utilised to improve the outcomes for children who are unwell and will focus on the results of one such investigation.